Researchers from KU Leuven and the Francis Crick Institute have pinpointed 27 novel genes thought to prevent cancer from forming. Their findings could help develop personalised cancer treatments that target these genes.
“Our cells have two copies of tumour suppressor genes that, when lost in mutated cells, cause cancer,” says Jonas Demeulemeester. “Using a new statistical model, we’ve uncovered 27 novel tumour suppressor genes.” Similar to the two sets of brakes on a bicycle, both copies of the gene need to be lost in order to release the ‘brakes’ on tumour formation.
These double gene copy deletions can provide clues for tumour suppressor genes in cancer. However, cancer samples normally contain both healthy cells and cancerous cells in unknown proportions, making it difficult to work out if just a single copy or both copies of the gene have been lost in the cancer cells. In addition, it can be difficult to distinguish between harmful deletions of tumour suppressor genes and non-harmful deletions of other genes at fragile sites along the genome.
The team developed computational tools to overcome these issues and used them to analyse 2,218 tumours from 12 cancer types including breast, lung and bowel cancers. By determining the relative proportions of cancerous and healthy cells in each sample, they could work out the number of copies of each gene in the cancer cells. This analysis revealed 96 regions of the human genome that are frequently lost during tumour development.
The analysis also revealed that harmful tumour suppressor gene deletions have a different ‘DNA footprint’ to non-harmful deletions, which tend to be much smaller. This enabled the researchers to categorize the 96 deletions, revealing 16 previously known tumour suppressor genes, and 27 new ones. Some of these had previously been suspected to contribute to cancer development, while others were completely new.
“Our study demonstrates that rare tumour suppressor genes can be identified through large-scale analysis of the number of copies of genes in cancer samples,” says Professor Peter Van Loo. “Cancer genomics is a growing area of research, and the computational tools we use are a powerful way to find new genes involved in cancer.”
The new candidate tumour suppressor genes identified in this study can be investigated by scientists in the laboratory to understand their mechanism of action, and try to find drugs targets.
This study was led by researchers at KU Leuven and the Francis Crick Institute, in collaboration with the University of Chicago and the University of Oslo.
Source: KU Leuven